我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
157
14 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1902
进行中(未招募)
4
2.5%
已完成
89
56.7%
Enrolling By Invitation
2
1.3%
尚未招募
8
5.1%
招募中
18
11.5%
暂停
1
0.6%
终止
10
6.4%
Unknown
20
12.7%
撤回
5
3.2%
暂无批准数据
- Analysis published in Cancer projects 28.4 million new cancer cases worldwide by 2040, with low-income countries facing disproportionately higher mortality rates despite global treatment advances. - Research reveals significant economic barriers in cancer care, with low-income nations paying more for essential cancer drugs while spending less of their GDP on overall cancer treatment. - Study proposes solutions including price discrimination, international funding, and improved screening methods to address growing disparities in global cancer care access.